Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients

• Status: Completed
• Trial end date: 2016-06-25
• Target enrollment: 0
• Participant gender: All

Summary

Purpose of this study was to assess the efficacy of aerosolized midazolam, introduced through buccal versus intranasal mucosa in managing uncooperative children undergoing dental treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nourhan M.Aly
• Collaborator: Alexandria University
• Treatments: Midazolam

Criteria

Inclusion Criteria:

• Negative and definitely negative behavior according Frankl's scale.

• ASA Group I (normal healthy patient without systemic disease) and II (patient with mild systemic disease) with no medical contraindication which rules out the use of midazolam.

• Children with at least two carious lesions requiring dental intervention in two settings of not more than 30 minute each.

Exclusion Criteria:

• Children with multiple carious lesions who require treatment under general anesthesia.